Credit Agricole’s Immunic IMUX Stock Holding History

Credit Agricole’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-970	Closed	-$97K	–	524
2019 Q3	$97K	Hold	970	–	–	﹤0.01%	351
2019 Q2	$111K	Buy	+970	New	+$127K	0.01%	342

Other funds holding IMUX

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Credit Agricole's IMUX Position: Q4 2019 in Review

Credit Agricole sold out of Immunic (IMUX) in Q4 2019, closing a stake of 970 shares — an estimated $97K sold.

Credit Agricole first reported a position in IMUX in Q2 2019 and held it in 2 quarters. The position peaked at $111K in Q2 2019. 20 funds tracked by Wall St. Rank hold IMUX as of Q4 2019.

Credit Agricole reported no remaining Immunic position as of Q4 2019 after selling out during the quarter.
Credit Agricole sold 970 Immunic shares in Q4 2019, an estimated $97K.
Credit Agricole first reported a position in Immunic in Q2 2019 and held it in 2 quarters.
Credit Agricole's Immunic position peaked at $111K in Q2 2019.
20 funds tracked by Wall St. Rank held Immunic as of Q4 2019.

Based on Credit Agricole's 13F filing for Q4 2019, filed 12 Feb 2020.